LLY Related Management Changes
-
Eli Lilly (LLY) CEO Lechleiter to Take Scheduled Medical Leave
-
AMAG Pharmaceuticals (AMAG) Adds Rajiv De Silva and Gino Santini to Board
-
Eli Lilly (LLY) Reports Shift in Management Following Departure of Carmine, Deane
-
Chiquita Brands (CQB) Appoints Jeffrey Simmons to Board of Directors
-
Savient Pharma (SVNT) Appoints John Johnson as CEO
-
Icahn Gets Another Seat on Biogen (BIIB) Board
-
Eli Lilly (LLY) SVP and CFO Derica Rice Promoted to EVP and CFO
-
Dendreon (DNDN) Appoints Ian Clark and Pedro Granadillo to Board of Directors
-
Eli Lilly (LLY) Announces Changes Across its Executive Leadership Structure
-
GlaxoSmithKline (GSK) Announces Growth Plan For Emerging Markets; Names Corporate Executive Team
-
Lilly (LLY) Announced Sidney Taurel To Retire As CEO At End of March
-
Eli Lilly (LLY) Appoints Dr. Frank Deane as President, Manufacturing
-
Eli Lilly (LLY) Announces Senior Management Additions
-
ICOS Corporation (ICOS) to Receive $34 Per Share From Eli Lilly (LLY) in Amended Merger Agreement
-
Eli Lilly and Company (LLY) Names Rich Pilnik as Group Vice President and Chief Marketing Officer
-
LLY Announces Retirement of CFO
-
LLY Names Connelly President of Lilly USA
Back to LLY Stock Lookup
